case 4: considering special populations in bladder cancer
Published 4 years ago • 10 plays • Length 8:29Download video MP4
Download video MP3
Similar videos
-
4:24
case 4: multiple lines of therapy in recurrent bladder cancer
-
7:18
case 3: experience with fgfr-targeted therapies in bladder cancer
-
7:12
case 3: molecular testing in bladder cancer
-
8:35
case 1: novel agents in superficial bladder cancer
-
6:38
case 2: exciting new treatment for cis-ineligible bladder cancer
-
6:58
case 2: factors in treating cis-ineligible bladder cancer
-
4:18
case 3: treatment for fgfr3 bladder cancer
-
43:17
case-based panel discussion: muscle-invasive bladder cancer
-
1:08
case 2: cisplatin-ineligible metastatic bladder cancer
-
2:16
dr. powles on biomarkers for immunotherapy in bladder cancer
-
8:24
case 2: combination therapy for cis-ineligible bladder cancer
-
1:09:47
evidence and insights on innovative treatment for bladder cancer
-
2:01:11
bladder cancer treatment dilemmas: the cases you face and what to do about them webcast (2022)
-
1:54
targeted therapy effective for patients with advanced bladder cancer and specific gene mutations
-
1:45:10
masterclass in bladder cancer
-
1:03:24
bladder cancer: understanding immune-, targeted-, and antibody-based models for patient care
-
22:27
2021 west oncology | genitourinary cancers | latest updates on advanced bladder cancer
-
1:14:45
advancing bladder cancer care with novel therapeutics
-
40:12
improving patient outcomes in urothelial carcinoma with novel antibody–drug conjugates